Cutler Group LP Spectrum Pharmaceuticals Inc Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$0.43 - $1.56 $258 - $936	-600 Reduced 31.58%	1,300 $0
Q2 2022 Aug 04, 2022	SELL	$0.7 - $1.4 $1,330 - $2,660	-1,900 Reduced 50.0%	1,900 $0
Q1 2022 Apr 14, 2022	BUY	$0.63 - $1.59 $2,331 - $5,883	3,700 Added 3700.0%	3,800 $0
Q4 2019 Feb 06, 2020	SELL	$3.5 - $10.35 $1,050 - $3,105	-300 Reduced 75.0%	100 $0
Q4 2017 Jan 17, 2018	BUY	$13.36 - $20.73 $5,344 - $8,292	400	400 $1,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.